SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Costantino who wrote (1205)8/15/1997 4:58:00 PM
From: Richard Belanger   of 1762
 
All - There was an interesting development today that is likely to have a positive effect on IDPH somewhere down the line. As I'm sure most of you know, Idec's Y2B8 uses the radioisotope Y-90. But it is less well known that the only suppliers of Y-90 (and MOST of the other radioisotopes used in nuclear medicine) are foreign-based. This reliance on foreign suppliers has been a real concern to the U.S. medical community, and nearly reached a crisis level earlier this year when a labor strike in Canada threatened to halt the supply of Mo-99, the isotope used more frequently than all others combined.

Today, there was an IPO for a development stage company called International Isotopes. Among other things, this company has acquired the linear accelerator which was built as part of the doomed superconducting super collider project (in Texas), and is converting it to produce medical isotopes, for which they see a greatly expanding market. Y-90 is listed among the isotopes they intend to produce. They are shooting for commercial isotope production by March 1998. Press release is at:

biz.yahoo.com

This development is not likely to move IDPH's price (at least not anytime soon), but it is one less thing to worry about down the road.

Rich
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News